These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 15472411

  • 1. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S, Pandita R, Bavishi K, Kreze O.
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN, Savchenko VG, Kliasova GA, Isaev VG, Demidova IA, Ol'shanskaia IuV, Tiurina NG, Tikhonova LIu, Galstian GM, Pivnik AV.
    Ter Arkh; 1999 Sep; 71(7):20-4. PubMed ID: 10481862
    [Abstract] [Full Text] [Related]

  • 7. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD.
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [Abstract] [Full Text] [Related]

  • 12. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Jan; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

  • 13. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 14. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
    Adès L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Maloisel F, Deconinck E, Ferrant A, Thomas X, Fegueux N, Chomienne C, Dombret H, Degos L, Fenaux P, European Acute Promyelocytic Leukemia Group.
    J Clin Oncol; 2006 Dec 20; 24(36):5703-10. PubMed ID: 17116939
    [Abstract] [Full Text] [Related]

  • 15. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 20; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 16. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 20; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 17. Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
    Fenaux P.
    Leukemia; 1994 Aug 20; 8 Suppl 3():S70-2. PubMed ID: 7808029
    [Abstract] [Full Text] [Related]

  • 18. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ, Morales-Toquero A, Gómez-Rangel JD, López-Martínez B, Ruiz-Delgado GJ, Reyes-Núñez V.
    Rev Invest Clin; 2005 Aug 20; 57(3):415-9. PubMed ID: 16187701
    [Abstract] [Full Text] [Related]

  • 19. [Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].
    Maeda A, Kobayashi Y, Saito T, Togitani K, Kawahigashi N, Tanosaki R, Takaue Y, Takenaka T, Iwata N, Tobinai K.
    Rinsho Ketsueki; 1999 Oct 20; 40(10):1081-6. PubMed ID: 10565225
    [Abstract] [Full Text] [Related]

  • 20. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH.
    N Engl J Med; 1997 Oct 09; 337(15):1021-8. PubMed ID: 9321529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.